Therapeutic Options in Docetaxel-Refractory Metastatic Castration-Resistant Prostate Cancer: A Cost-Effectiveness Analysis

• Lixian Zhong,

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Vickie Pon,

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Sandy Srinivas,

  Affiliations VA Northern California, Martinez, California, United States of America, Stanford University Medical Center, Palo Alto, California, United States of America

  ⨯
• Nicole Nguyen,

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Meghan Frear,

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Sherry Kwon,

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Cynthia Gong,

  Affiliation VA Northern California, Martinez, California, United States of America

  ⨯
• Robert Malmstrom,

  Affiliation VA Northern California, Martinez, California, United States of America

  ⨯
• Leslie Wilson

  * E-mail: WilsonL@pharmacy.ucsf.edu

  Affiliation University of California San Francisco, San Francisco, California, United States of America

  ⨯